France· FR:65000788
ZYPADHERA 300 mg, poudre et solvant pour suspension injectable à libération prolongée
A medicinal product containing olanzapine (pamoate d') monohydraté, registered in France by CHEPLAPHARM REGISTRATION (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OLANZAPINE (PAMOATE D') MONOHYDRATÉ
- Manufacturer
- CHEPLAPHARM REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009574692211 flacon(s) en verre - 1 flacon(s) en verre de 3 ml avec seringue(s) avec aiguille(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51c78758-42d8-4ac2-9aba-99cce8c08025 GET /v1/drugs/51c78758-42d8-4ac2-9aba-99cce8c08025?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65000788",
"date_amm": "2008-11-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/479",
"substance": "OLANZAPINE (PAMOATE D') MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour suspension injectable à libération prolongée",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about olanzapine (pamoate d') monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.